Bradley Foster & Sargent’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $242K | Buy |
622
+87
| +16% | +$33.8K | ﹤0.01% | 500 |
|
2025
Q1 | $233K | Buy |
+535
| New | +$233K | ﹤0.01% | 440 |
|
2024
Q4 | – | Sell |
-601
| Closed | -$313K | – | 469 |
|
2024
Q3 | $313K | Sell |
601
-6
| -1% | -$3.12K | 0.01% | 406 |
|
2024
Q2 | $329K | Sell |
607
-25
| -4% | -$13.5K | 0.01% | 397 |
|
2024
Q1 | $328K | Hold |
632
| – | – | 0.01% | 390 |
|
2023
Q4 | $298K | Buy |
632
+1
| +0.2% | +$472 | 0.01% | 392 |
|
2023
Q3 | $280K | Hold |
631
| – | – | 0.01% | 395 |
|
2023
Q2 | $280K | Sell |
631
-199
| -24% | -$88.4K | 0.01% | 395 |
|
2023
Q1 | $382K | Sell |
830
-6
| -0.7% | -$2.76K | 0.01% | 355 |
|
2022
Q4 | $429K | Sell |
836
-375
| -31% | -$192K | 0.01% | 343 |
|
2022
Q3 | $550K | Sell |
1,211
-323
| -21% | -$147K | 0.02% | 298 |
|
2022
Q2 | $740K | Hold |
1,534
| – | – | 0.02% | 269 |
|
2022
Q1 | $754K | Buy |
1,534
+174
| +13% | +$85.5K | 0.02% | 292 |
|
2021
Q4 | $630K | Sell |
1,360
-16
| -1% | -$7.41K | 0.01% | 303 |
|
2021
Q3 | $513K | Buy |
1,376
+163
| +13% | +$60.8K | 0.01% | 299 |
|
2021
Q2 | $463K | Hold |
1,213
| – | – | 0.01% | 313 |
|
2021
Q1 | $435K | Sell |
1,213
-7
| -0.6% | -$2.51K | 0.01% | 306 |
|
2020
Q4 | $392K | Buy |
1,220
+53
| +5% | +$17K | 0.01% | 311 |
|
2020
Q3 | $313K | Buy |
+1,167
| New | +$313K | 0.01% | 295 |
|
2020
Q1 | $265K | Sell |
1,167
-6
| -0.5% | -$1.36K | 0.01% | 293 |
|
2019
Q4 | $354K | Buy |
1,173
+6
| +0.5% | +$1.81K | 0.01% | 304 |
|
2019
Q3 | $280K | Hold |
1,167
| – | – | 0.01% | 303 |
|
2019
Q2 | $329K | Buy |
1,167
+47
| +4% | +$13.3K | 0.01% | 294 |
|
2019
Q1 | $321K | Hold |
1,120
| – | – | 0.01% | 297 |
|
2018
Q4 | $294K | Hold |
1,120
| – | – | 0.01% | 295 |
|
2018
Q3 | $307K | Hold |
1,120
| – | – | 0.01% | 319 |
|
2018
Q2 | $267K | Hold |
1,120
| – | – | 0.01% | 334 |
|
2018
Q1 | $246K | Buy |
1,120
+7
| +0.6% | +$1.54K | 0.01% | 328 |
|
2017
Q4 | $250K | Buy |
1,113
+50
| +5% | +$11.2K | 0.01% | 326 |
|
2017
Q3 | $202K | Buy |
+1,063
| New | +$202K | 0.01% | 351 |
|